ACHIEVE YOUR NEXT BREAKTHROUGH
using the world’s most powerful 3D in situ
multi-omic analysis technology
WHY STELLAROMICS
Empowering a brighter biomedical future
Welcome to the new world of in situ analysis. Now you can capture high resolution 3D multi-omic information from thick tissue samples, mapping gene expression patterns while preserving the spatial integrity and anatomical structure of the cells in the tissue being studied.
STELLAR TECHNOLOGY
Faster, richer discovery straight from the STARs
Stellaromics uses industry-leading STARmap (Spatially-resolved Transcript Amplicon Readout mapping) technology to optically extract multi-omic information from biologic tissue so researchers can better understand tissue functions and dysfunctions, in which cells may be targeted by specific interventions.
INTRODUCING PLEXA
TM
Powerful, fully annotated multi-omic maps at your fingertips
Discover how individual cells work and how multiple cell types relate to each other across imaging layers using the Stellaromics Plexa suite of devices, reagents, software, and services. Plexa starter kit available now to be tested in your favorite tissues. Also inquiry and preorder the Plexa In Situ Analyzer for early access.
ABOUT STELLAROMICS
Power. Precision. Innovation. Ingenuity.
Stellaromics was founded in 2022 by a team of world renowned scientists on a mission to move biomedical research forward faster. The Plexa suite of products was developed to extend their progress by empowering others to innovate alongside them.
Stellaromics In Numbers
1 cent
Cell transcriptome profiling within 1 cent/cell
4000 genes
Imaging up to 4000 genes at once
40 nt
Targeting RNA species as short as 40 nucleotides
1 million
Studying 1 million cells per experiment
200 um
Analyzing biologic tissue up to 200 um thickness
200 nm
Achieving spatial resolution of 200 nm